首页> 外文期刊>BMC Veterinary Research >Porcine Mx1 fused to HIV Tat protein transduction domain (PTD) inhibits classical swine fever virus infection in vitro and in vivo
【24h】

Porcine Mx1 fused to HIV Tat protein transduction domain (PTD) inhibits classical swine fever virus infection in vitro and in vivo

机译:融合到HIV Tat蛋白转导域(PTD)的猪Mx1在体外和体内抑制经典猪瘟病毒感染

获取原文
           

摘要

Background Classical swine fever (CSF) caused by CSF virus (CSFV) is highly contagious andcauses significant economic losses in the pig industry throughout the world. Previously we demonstrated that porcine Mx1 (poMx1), when fused to HIV Tat protein transduction domain (PTD), inhibits CSFV propagation in PK-15 cells, but it is unknown whether PTD-poMx1 exhibits antiviral activity in other porcine lines and it is efficacious for controlling CSFV infection in pigs in China. Methods Two porcine cell lines, ST and 3D4/21, were used to investigate in vitro antiviral activity of PTD-poMx1 against CSFV using confocal microscopy, western blot, flow cytometry, and real-time RT-PCR. Furthermore, in vivo antiviral activity of PTD-poMx1 was assessed by means of rectal temperature, clinical score, pathological lesion, white blood cell count, viral load, etc. Results PTD-poMx1 entered both cell lines within 3 h and maintained for 16 h, but did not affect CSFV binding and uptake. Viral titers and qRT-PCR data showed that PTD-poMx1 inhibited CSFV replication in both cell lines, showing significant antiviral activity after infection. Injection of PTD-poMx1 into CSFV-challenged pigs attenuated CSFV symptoms and viremia in dose-dependent manner but did not completely block virus replication within 14 days post challenge, suggesting that PTD-poMx1 confers partial protection against a lethal challenge. Conclusion We demonstrated the anti-CSFV activity of PTD-poMx1 in vitro and in vivo. The results have shown that treatment with PTD-poMx1 alleviated symptoms and viral load in infected pigs. The results support our previous in vitro studies and suggest that PTD-poMx1 could be promising in reducing the clinical signs caused by CSFV.
机译:背景技术由CSF病毒(CSFV)引起的经典猪瘟(CSF)具有高度传染性,并在全世界的养猪业中造成重大的经济损失。先前我们证明,猪Mx1(poMx1)与HIV Tat蛋白转导域(PTD)融合时,可抑制CSFV在PK-15细胞中的繁殖,但尚不清楚PTD-poMx1是否在其他猪系中表现出抗病毒活性且是否有效在中国控制猪的猪瘟病毒感染。方法采用共聚焦显微镜,western blot,流式细胞术和实时RT-PCR技术,用两种猪细胞系ST和3D4 / 21研究PTD-poMx1对CSFV的体外抗病毒活性。此外,通过直肠温度,临床评分,病理病变,白细胞计数,病毒载量等方法评估了PTD-poMx1的体内抗病毒活性。结果PTD-poMx1在3 h内进入两种细胞系并维持16 h ,但不影响CSFV的结合和摄取。病毒滴度和qRT-PCR数据显示,PTD-poMx1抑制了两种细胞系中的CSFV复制,在感染后显示出显着的抗病毒活性。向受CSFV攻击的猪中注射PTD-poMx1以剂量依赖的方式减弱了CSFV症状和病毒血症,但在攻击后14天内并未完全阻断病毒复制,这表明PTD-poMx1赋予了针对致命攻击的部分保护。结论我们证明了PTD-poMx1在体外和体内的抗CSFV活性。结果表明,用PTD-poMx1处理可减轻感染猪的症状和病毒载量。该结果支持了我们之前的体外研究,并提示PTD-poMx1在减少CSFV引起的临床体征方面可能很有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号